Keywords: corcept, initiates, fourth, ph, ii, corlux, study

Corcept initiates fourth Ph II Corlux study

Article | 31 March 2008

Corcept Therapeutics has announced the commencement of its fourth Phase III trial, Study 14, evaluating Corlux (mifepristone) for the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Mifeprex

Mifepristone

Go to drug listing